share_log

康希諾生物：股份發行人的證券變動月報表

CANSINOBIO: Monthly Return of Equity Issuer on Movements in Securities

香港交易所 ·  Feb 2 01:58
Summary by Moomoo AI
康希諾生物股份公司於2024年2月2日向香港交易及結算所有限公司提交了截至2024年1月31日的證券變動月報表。報告顯示，公司的H股和A股在1月份均無增減，H股結存為132,670,900股，A股結存為114,778,999股。此外，公司於2022年1月23日董事會通過的A股回購方案下，從2022年2月7日至2022年12月1日期間回購了406,098股A股，但未進行注銷。公司確認2024年1月期間沒有進行A股回購。報告中亦提到，截至2024年1月31日，根據2021年限制性股票激勵計劃授出的1,095,380股限制性股票已全部被收回。
康希諾生物股份公司於2024年2月2日向香港交易及結算所有限公司提交了截至2024年1月31日的證券變動月報表。報告顯示，公司的H股和A股在1月份均無增減，H股結存為132,670,900股，A股結存為114,778,999股。此外，公司於2022年1月23日董事會通過的A股回購方案下，從2022年2月7日至2022年12月1日期間回購了406,098股A股，但未進行注銷。公司確認2024年1月期間沒有進行A股回購。報告中亦提到，截至2024年1月31日，根據2021年限制性股票激勵計劃授出的1,095,380股限制性股票已全部被收回。
Consino Biologics Corporation filed with Hong Kong Trading and Settlement Limited on February 2, 2024 the Monthly Securities Change Report for the year ended January 31, 2024. The report showed that the company's H shares and A shares did not increase in January, with 132,670,900 shares in H shares and 114,778,999 shares in A shares. In addition, under the A share repurchase plan approved by the Board on January 23, 2022, the Company repurchased 406,098 shares of A-shares from February 7, 2022 to December 1, 2022, but no repurchase was made. The Company confirms that no A share repurchases were made during January 2024. The report also mentions that as of January 31, 2024, all 1,095,380 shares of restricted stock issued under the Restricted Stock Incentive Scheme 2021 have been withdrawn.
Consino Biologics Corporation filed with Hong Kong Trading and Settlement Limited on February 2, 2024 the Monthly Securities Change Report for the year ended January 31, 2024. The report showed that the company's H shares and A shares did not increase in January, with 132,670,900 shares in H shares and 114,778,999 shares in A shares. In addition, under the A share repurchase plan approved by the Board on January 23, 2022, the Company repurchased 406,098 shares of A-shares from February 7, 2022 to December 1, 2022, but no repurchase was made. The Company confirms that no A share repurchases were made during January 2024. The report also mentions that as of January 31, 2024, all 1,095,380 shares of restricted stock issued under the Restricted Stock Incentive Scheme 2021 have been withdrawn.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more